PTPRC and neoplasm: Especially exosomes carrying highly immunosuppressive cargo were reported to induce CD39 expression on CD4+ T cells [20], with the assumption that the cargo of CD45(−) exosomes of high stage patients is especially enriched in immune-suppressive molecules, inhibiting an anti-tumor immune response in the TME.